BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2061925)

  • 1. Synthesis and anticonvulsant activity of 2-iminohydantoins.
    Kwon CH; Iqbal MT; Wurpel JN
    J Med Chem; 1991 Jun; 34(6):1845-9. PubMed ID: 2061925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity study of 5-substituted 1-carbobenzoxy-2-iminohydantoins as potential anticonvulsant agents.
    Sun ZY; Kwon CH; Wurpel ND
    J Med Chem; 1994 Sep; 37(18):2841-5. PubMed ID: 8071932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and potential anticonvulsant activity of new N-3-substituted 5,5-cyclopropanespirohydantoins.
    Zhu Q; Pan Y; Xu Z; Li R; Qiu G; Xu W; Ke X; Wu L; Hu X
    Eur J Med Chem; 2009 Jan; 44(1):296-302. PubMed ID: 18396358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and anticonvulsant activity of N-3-arylamide substituted 5,5-cyclopropanespirohydantoin derivatives.
    He X; Zhong M; Zhang T; Wu W; Wu Z; Yang J; Xiao Y; Pan Y; Qiu G; Hu X
    Eur J Med Chem; 2010 Dec; 45(12):5870-7. PubMed ID: 20947222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of structural modification of the hydantoin ring on anticonvulsant activity.
    Cortes S; Liao ZK; Watson D; Kohn H
    J Med Chem; 1985 May; 28(5):601-6. PubMed ID: 3989820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of novel parabanic acid derivatives as anticonvulsants.
    Aboutabl ME; Hassan RM; El-Azzouny AA; Aboul-Enein MN; Abd-Allah WH
    Bioorg Chem; 2020 Jan; 94():103473. PubMed ID: 31831160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticonvulsants. 5. Derivatives of 5-ethyl-5-phenylhydantoin and 5,5-diphenylhydantoin.
    Vida JA; O'Dea MH; Samour CM; Reinhard JF
    J Med Chem; 1975 Apr; 18(4):383-5. PubMed ID: 1121005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential anticonvulsants. 1. 5-Benzylhydantoins.
    Mehta NB; Diuguid CA; Soroko FE
    J Med Chem; 1981 Apr; 24(4):465-8. PubMed ID: 7265133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Evaluation of Novel Diazaspiro Hydantoins as Potential Anticonvulsants.
    Kumar CSA; Veeresh B; Ramesha KC; Raj CSA; Mahadevaiah KM; Prasad SBB
    Cent Nerv Syst Agents Med Chem; 2017; 17(3):201-208. PubMed ID: 28707581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticonvulsant activity of reaction products of 5,5-diphenylhydantoin with substituted methylene bromides.
    Usifoh CO
    Arch Pharm (Weinheim); 2001 Nov; 334(11):366-8. PubMed ID: 11822175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A spirohydantoin derivative of dimethoxytetrahydronaphthalene: an experimental anticonvulsant.
    Alexander GJ; Sinha B; Chatterjie N
    Neurochem Res; 1984 Apr; 9(4):529-33. PubMed ID: 6547772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticonvulsant activity of phenylmethylenehydantoins: a structure-activity relationship study.
    Thenmozhiyal JC; Wong PT; Chui WK
    J Med Chem; 2004 Mar; 47(6):1527-35. PubMed ID: 14998338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of new antiepileptics. II. Anticonvulsant effect of hydantoin derivatives].
    Waser PG; Ganz AJ; Pfirrmann RW
    Arzneimittelforschung; 1977; 27(11):2125-8. PubMed ID: 580013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and Synthesis of 5-Substituted Benzo[d][1,3]dioxole Derivatives as Potent Anticonvulsant Agents.
    Dong S; Wang T; Hu C; Chen X; Jin Y; Wang Z
    Arch Pharm (Weinheim); 2017 Feb; 350(2):. PubMed ID: 28092111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and anticonvulsant activity of new N-Mannich bases derived from spirosuccinimides and spirohydantoins.
    Obniska J; Byrtus H; Kamiński K; Pawłowski M; Szczesio M; Karolak-Wojciechowska J
    Bioorg Med Chem; 2010 Aug; 18(16):6134-42. PubMed ID: 20638856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Anticonvulsant Activity of N-(Substituted)-1-methyl-2,4-dioxo-1,2-dihydroquinazoline-3(4H)-carboxamides.
    Deepakumari HN; Jayanna BK; Prashanth MK; Revanasiddappa HD; Veeresh B
    Arch Pharm (Weinheim); 2016 Jul; 349(7):566-71. PubMed ID: 27231098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenytoin-based bivalent ligands: design, synthesis and anticonvulsant activity.
    Botros S; Khalil NA; Naguib BH; El-Dash Y
    Arch Pharm Res; 2012 Dec; 35(12):2105-16. PubMed ID: 23263804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A search for new anticonvulsant compounds among 3-aryl-5-benzylidene derivatives of 2-thiohydantoin.
    Korohoda MJ; Kleinrok Z; Przegaliński E
    Pol J Pharmacol Pharm; 1976; 28(4):329-33. PubMed ID: 981022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and anticonvulsant activity of new n-mannich bases derived from 5-cyclopropyl-5-phenyl-hydantoins.
    Byrtus H; Obniska J; Czopek A; Kamiński K
    Arch Pharm (Weinheim); 2011 Apr; 344(4):231-41. PubMed ID: 21469172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and anticonvulsant activity of 4-oxo and 4-thioxo-8-bromobenzopyran derivatives.
    Ragab FA; Hassan GS; Abu Yossef HA; Yahya TA; Abd El-Latif HA
    Arzneimittelforschung; 2010; 60(4):171-6. PubMed ID: 20486465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.